Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,547 | 48 | 71.9% |
| Travel and Lodging | $504.68 | 2 | 23.4% |
| Education | $100.99 | 2 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $723.55 | 4 | $0 (2018) |
| Boston Scientific Corporation | $430.41 | 12 | $0 (2024) |
| COLOPLAST CORP | $201.94 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $197.02 | 10 | $0 (2020) |
| PFIZER INC. | $146.64 | 4 | $0 (2024) |
| Teleflex LLC | $131.24 | 1 | $0 (2022) |
| Olympus America Inc. | $83.11 | 2 | $0 (2021) |
| Verity Pharmaceuticals Inc. | $80.06 | 4 | $0 (2024) |
| HealthTronics Mobile Solutions, LLC | $66.22 | 1 | $0 (2019) |
| ABBVIE INC. | $39.52 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $310.21 | 10 | Boston Scientific Corporation ($131.50) |
| 2023 | $212.30 | 10 | Boston Scientific Corporation ($129.08) |
| 2022 | $155.86 | 3 | Teleflex LLC ($131.24) |
| 2021 | $209.99 | 4 | BOSTON SCIENTIFIC CORPORATION ($121.81) |
| 2020 | $18.51 | 1 | Astellas Pharma US Inc ($18.51) |
| 2019 | $180.68 | 6 | HealthTronics Mobile Solutions, LLC ($66.22) |
| 2018 | $216.42 | 8 | Astellas Pharma US Inc ($124.05) |
| 2017 | $848.40 | 10 | NeoTract Inc. ($646.08) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $18.47 | General |
| Category: Prostate cancer | ||||||
| 07/30/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $35.84 | General |
| Category: Men's Health | ||||||
| 05/23/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $17.66 | General |
| Category: Prostate cancer | ||||||
| 04/11/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: ONCOLOGY | ||||||
| 03/14/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Men's Health | ||||||
| 02/18/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: Prostate cancer | ||||||
| 02/15/2024 | Boston Scientific Corporation | NephroMax (Device) | Food and Beverage | In-kind items and services | $117.53 | General |
| Category: NephroMax_URO | ||||||
| 01/12/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: LithoVue_URO | ||||||
| 01/02/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Men's Health | ||||||
| 12/07/2023 | Coloplast Corp | Titan (Device) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Men's Health | ||||||
| 11/23/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $23.68 | General |
| Category: Prostate cancer | ||||||
| 11/13/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $4.41 | General |
| Category: LithoVue_URO | ||||||
| 10/06/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: LithoVue_URO | ||||||
| 09/27/2023 | Coloplast Corp | Titan (Device) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Men's Health | ||||||
| 09/21/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $86.68 | General |
| Category: LithoVue_URO | ||||||
| 09/15/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: LithoVue_URO | ||||||
| 07/12/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: ONCOLOGY | ||||||
| 06/07/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: rezum_URO | ||||||
| 04/19/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 11/08/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/20/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $131.24 | General |
| Category: Interventional Urology | ||||||
| 04/05/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/08/2021 | BOSTON SCIENTIFIC CORPORATION | AMS 700 CXR RTE KIT (Device) | Food and Beverage | In-kind items and services | $115.15 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/16/2021 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $67.18 | General |
| Category: Urology Gynecology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 346 | 461 | $111,509 | $29,263 |
| 2022 | 3 | 348 | 425 | $94,075 | $25,670 |
| 2021 | 6 | 447 | 562 | $140,247 | $36,409 |
| 2020 | 6 | 457 | 550 | $111,051 | $23,735 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 303 | 417 | $91,750 | $25,673 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,804 | $1,590 | 23.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $5,415 | $1,176 | 21.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 13 | 13 | $7,540 | $823.26 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 305 | 380 | $83,518 | $22,831 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $6,854 | $1,786 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 26 | $3,702 | $1,053 | 28.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 325 | 433 | $94,603 | $27,618 | 29.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $9,670 | $2,314 | 23.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 20 | $9,084 | $2,189 | 24.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 52 | $7,404 | $2,093 | 28.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 17 | 19 | $11,020 | $1,102 | 10.0% |
| 55700 | Biopsy of prostate gland | Office | 2021 | 11 | 11 | $8,467 | $1,092 | 12.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 192 | 244 | $53,181 | $12,526 | 23.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 219 | 256 | $36,625 | $7,996 | 21.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $4,348 | $1,156 | 26.6% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 11 | 14 | $8,120 | $763.40 | 9.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 13 | $5,866 | $723.03 | 12.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $2,911 | $570.27 | 19.6% |
About Dr. Robert Wake, MD
Dr. Robert Wake, MD is a Urology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982661088.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Wake, MD has received a total of $2,152 in payments from pharmaceutical and medical device companies, with $310.21 received in 2024. These payments were reported across 52 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,547).
As a Medicare-enrolled provider, Wake has provided services to 1,598 Medicare beneficiaries, totaling 1,998 services with total Medicare billing of $115,077. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Memphis, TN
- Active Since 05/01/2006
- Last Updated 03/03/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1982661088
Products in Payments
- Urolift - UL400 (Device) $646.08
- MYRBETRIQ (Drug) $146.91
- XTANDI (Drug) $139.01
- UROLIFT (Device) $131.24
- LithoVue (Device) $122.79
- NephroMax (Device) $117.53
- Titan (Device) $116.54
- AMS 700 CXR RTE KIT (Device) $115.15
- TITAN (Device) $85.40
- Trelstar (Drug) $80.06
- UroLift (Device) $77.47
- iTIND System (Device) $67.18
- Mobile Cryoblation Services (Device) $66.22
- Xtandi (Drug) $30.25
- LITHOVUE (Device) $27.28
- LUPRON DEPOT (Drug) $24.62
- ORGOVYX (Drug) $21.00
- GENERAL ERECTILE DYSFUNCTION (Device) $20.74
- VESICARE (Drug) $19.86
- ADSTILADRIN (Biological) $19.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Memphis
David Gubin, Md, MD
Urology — Payments: $1.1M
Mark Greenberger, M.d, M.D
Urology — Payments: $250,760
Dr. Mark Saslawsky, M.d, M.D
Urology — Payments: $32,854
Dr. Walter Rayford, M.d., Phd., Facs, M.D., PHD., FACS
Urology — Payments: $27,437
William Bingham, M.d, M.D
Urology — Payments: $11,128
Dr. Gerald Dang, M.d, M.D
Urology — Payments: $11,018